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Abstract
The chicken has led the way among agricultural animal species in in-
fectious disease control and, in particular, selection for genetic re-
sistance. The generation of the chicken genome sequence and the
availability of other empowering tools and resources greatly enhance
the ability to select for enhanced disease resistance via geneticmarkers
and to understand more deeply the biological basis of host resistance.
In this review,we discuss how integrated genomic approaches are able
to identify specific genes and genetic markers associated with disease
resistance, give select examples of contemporary work involving var-
ious genomic strategies to identify disease resistance genes, and finish
by giving some final thoughts on predicted applications in the near
future.
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INTRODUCTION
Modern agriculture has been very successful in meeting the growing demands of consumers for
high-quality, safe, and affordable products. This trend is particularly evident in the poultry in-
dustry. As determined by the Food and Agriculture Organization (1), worldwide per capita
consumption of poultrymeat has gone from2.87 kg per year in 1961 to 12.62 kg per year in 2007,
a more than fourfold increase during this period. Furthermore, this dynamic growth trend is
projected to continue, with poultry overtaking pork as the main meat consumed worldwide
within the next five years.
Presently, several major issues confront the poultry industry in meeting the growing demands
of consumers. Control of infectious diseases and food safety is certainly at or near the top of the
list. Avian influenza, Salmonella, and Campylobacter are just a few of the pathogens well known
to the public that harm the poultry industry through birdmorbidity andmortality, reduced public
confidence, and/or lost market accessibility via trade restrictions. Disease outbreaks, or the po-
tential for them to occur, are enhanced by both high-density and free-range chicken rearing,
reduced genetic diversity from continued industry consolidation, and government restrictions
on chemoprophylactics to control pathogens. Changes in animal husbandry and new vaccines
have helped to alleviate some of the problems; however, improved or alternative control
measures are still needed to address current diseases and impede emerging threats.
The field of genomics offers a very exciting avenue for solving or ameliorating many of these
issues. Although still in its formative years, by identifying quantitative trait loci (QTLs) and genes
that control heritable traits of agricultural importance, it is possible to use refined knowledge
about existing biodiversity to genetically select for birds with superior agricultural traits, such as
improved disease resistance, via marker-assisted selection (MAS). For infectious diseases, MAS
would eliminate the exposure risk to elite flocks associated with handling a hazardous pathogen,
which traditionally is needed to select for more disease-resistant birds. The release of the chicken
genome sequence in 2004 (2) and additional improvements since then toward finishing the as-
sembly have only increased the power of this discipline. The ultimate goal is to address the long-
standing, major biological question of how genetic variation explains the observed phenotypic
(i.e., connecting genotype-to-phenotype) variation.
This review provides information on the emergence of modern molecular genetics in poultry
and gives specific examples of how the employment of integrated approaches is yielding results
with high potential for enhancing genetic resistance to three different pathogens, while also pre-
serving appropriate levels of production in commercial poultry. Although the focus is on chickens
and genetic resistance to disease in intensive production systems, the strategies, opportunities, and
challenges should be applicable to other species, including those with no or draft genome as-
semblies, which is becoming increasingly common owing to significant gains in next-generation
sequencing technologies.
POULTRY BREEDING AND DISEASE CONTROL
Poultry production has a long history of embracing and applying innovations to meet consumer
demands and improve profitability. Many key developments, especially since the 1950s, have
resulted in the highly efficient and specialized industry that exists andoperates today.Of particular
note are the tremendous advancements in poultry breeding that have resulted in commercial
chickens with greater genetic potential. Specifically, the primary breeding companies, which are
responsible for genetic improvements in poultry, have been able to continually select for birdswith
superior production and other agronomic traits. For example, a 2001 commercial broiler had an
average body weight of 3,946 g at 56 days of age, compared with 809 g for its 1957 counterpart
Quantitative trait loci
(QTLs): regions
containing one or more
genes that account for
genetic variation of
a complex trait
Marker-assisted
selection (MAS):
a method to select for
traits using genetic
markers
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(3). Utilizing feeds typical for years 1957 and 2001, it was shown that 85–90% of this 4.87-fold
improvement is accounted for by genetics; the remaining 10–15% is due to nutrition. These genetic
gains aremultiplied through the vertically integrated system of hatcheries, producers, and growers
to the consumer, with the net result being greater efficiency at all levels and lower commodity
prices. Other traits show similar gains, such as feed conversion rate (FCR), in which commercial
birds require 1.8 g or less of feed to gain 1 g of body weight; in comparison, FCR is ∼3.5 and 8 for
pigs and cattle, respectively (4, 5). In short, poultry is themost affordable source of animal-derived
protein, and its breeding methods are considered models for other animals.
Disease control and prevention was another critical factor in the dramatic growth of the
poultry industry. With the widespread distribution of poultry and high-intensity rearing, in-
fectious diseases could be spread and transmitted rapidly,which resulted in considerable economic
losses. Consequently, the demand by growers (and consumers, for zoonotic pathogens) forced the
industry to control specific diseases, which has been implemented through a combination of
biosecurity, chemoprophylactics, and vaccines as well as selection for genetic resistance, the focus
of this review.
POULTRY GENETICS IN THE POST–GENOME SEQUENCE ERA
Just prior to the release of the chicken genome sequence in 2004, there was great excitement in the
field of molecular genetics for chickens and other animal agricultural species (e.g., cattle, swine,
sheep). The main cause was that, armed with molecular genetic maps composed of several
thousand markers (mainly PCR-based microsatellite markers), scientists then felt they had the
ability to survey the entire genome and identify QTLs that could account for most genetic variation
observed for traits, including multifactorial ones such as disease resistance. Numerous studies, in
chicken and other species, indicated strongly that these QTLs are real and account for a significant
portion of the genetic variation. Thus, there was great hope that the identification of the underlying
genes andcausative polymorphismswould soonbe inhand for use in animal breeding throughMAS.
The advent of the genome sequence of red jungle fowl (2) only strengthened this expectation.
Not only did scientists have the “blueprint” for the chicken and knowledge of where most of the
genes lie in the genome, but newer discoveries and technologies continued to enhance the power of
genomics. Specifically, by sample sequencing three other diverse chickens (commercial broiler,
Chinese Silkie, and White Leghorn), a Beijing Genome Institute–led consortium identified ap-
proximately threemillion single-nucleotide polymorphisms (SNPs),which provided several orders
of magnitude more genetic markers (6). This identification, combined with the ability to ge-
notype first thousands (7) then tens to hundreds of thousands of SNPs (8), it was economically
feasible to genotype thousands of genetic markers for QTL scans. As a result, with the ability to
scan the entire genomewith hundreds to thousands ofmarkers, 3,162QTLs have been identified
in chicken from 158 publications (9).
Despite this success, it soon became apparent that theQTLmapping resolutionwas insufficient
for MAS for two main reasons: First, unless the individual QTL effects are large and the extent of
linkage disequilibrium (LD) very small, it is almost impossible to fine-map aQTLdown to 5 cMor
less; with ∼23,000 genes and ∼3,000 cM in the chicken genome, on average, each cM of the
chicken genome encompasses ∼7 genes. Second, sufficient mapping resolution requires small LD
blocks, which in turn require more genetic markers. This can be achieved easily by using resource
populations that have accumulated more recombination events, such as advanced intercross lines
or commercial populations. However, increasing the number of genetic markers also requires
increasing the number of measured animals; theoretically, the number of phenotyped animals
should equal or exceed the number of genetic markers. Although commercial poultry-breeding
Single-nucleotide
polymorphisms
(SNPs): the most
prevalent type of
polymorphism and
genetic marker
Linkage disequilibrium
(LD): the nonrandom
association of alleles at
two or more loci
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companies have the resources tomeasure tens of thousands of birds formany traits, this is often not
true for traits related to disease resistance. Therefore, although possible, it is unlikely that a purely
genetics-driven approach will be powerful enough to map a QTL down to the single gene level,
let alone the causative mutation. The inability to achieve mapping resolution sufficient to identify
individual genes and to account for themajority of the genetic variation is not unique to chicken, as
evidenced by similar issues in human genetics, towhich even greater genomic resources and efforts
have been devoted (10).
In addition, the inability to fine-map QTLs and results from other genomic approaches in
chicken and other species has led to numerous discussions questioning whether large-effect QTLs
truly exist. Prior to the identificationofQTLs, the“infinitesimal model,” originated by Fisher (11),
postulated that traits were controlled by many loci of relatively small effect. If the infinitesimal
model is true, then it would make implementing MAS for complex traits much more difficult
than originally anticipated. However, the chicken major histocompatibility complex (MHC)
and other loci with large effects have been identified and undergone commercial selection,
suggesting a more balanced view of biological reality, which likely includes genes of both small
and large effects. Fortunately, several existing tools can augment purely genetics-driven efforts.
Those that explore the biology at the genome-wide scale (i.e., functional genomics) include but
are not limited to the following.
RNA Expression Profiling
Differences in gene expression (when, where, how much) are thought to be major contributors to
phenotypic variation. Typically through microarrays or RNA sequencing, one can identify genes
that are differentially expressed between two or more samples. For disease challenges, this is
a powerful approach to determine what genes and associated pathways are altered when the host
encounters a specific pathogen. Because RNA is being measured, information on when and where
to isolate the RNA is relevant when using animals, and these factors are not always clear at
the beginning of a study. A major limitation of this approach is the limited annotation of genes in
the chicken genome, especially those involved in the immune system, although this is improving.
Expression Quantitative Trait Loci
Although RNA expression profiling can provide substantial insights into biological functions and
pathways associated with complex traits such as disease resistance, it cannot distinguish the ge-
netic basis for this variation in gene expression, because expression of all the genes downstream
from the causative variant potentially could be perturbed. To identify the genetic basis for ex-
pression variation, two approaches have been employed. The first is known as genetical genomics,
or eQTL (expressionQTL). In this method, transcript abundance levels are treated as quantitative
traits for QTL mapping. This allows molecular genetics to be combined with transcript profiling,
usually through microarrays. As a result, elements (eQTLs) that control the expression of genes
with heritable expression variation can be identified. These eQTLs are further defined as cis or
trans based on the genomic position of the eQTL relative to the gene it regulates. Thus, cis eQTLs
are believed to identify genes that account for a portion of the genetic basis. Unfortunately, eQTLs
suffer from the same mapping resolution issues inherent to QTL mapping.
Allele-Specific Expression Screens
An alternative to eQTL is allele-specific expression (ASE). With ASE, each allele is measured for
genes that are heterozygous as judged by a marker polymorphism (e.g., a SNP). When allelic
Major
histocompatibility
complex (MHC):
a 242-kb region in the
chicken genome
containing 46 genes,
many of which are key
immune regulators and
are in high linkage
disequilibrium
Expression
quantitative trait loci
(eQTLs): loci and
candidate genes with
cis- and trans-acting
genetic influences on
gene expression
Allele-specific
expression (ASE):
a genomic method to
identify genes with
cis-acting regulatory
elements from RNA
sequencing data sets
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imbalance or differential expression is observed, then a polymorphic cis-acting element must be
present for that gene, “since allelic variation is by definition reflective of cis-acting influence” (12,
p. 452). In fact, this is a primary strength of the ASE approach. As both alleles are present in
a diploid cell, if the alleles respond differentially, then thismust be a result of a cis-acting effect. Key
advantages of ASE over eQTL are that: (a) separation of an overall gene expression signal into
allelic components significantly increases sensitivity and adds power; (b) because both alleles of
the gene are in the same cell of an individual, monitoring the expression of each allele controls
for issues such as differences in cellular composition, sampling, RNA quality, or environmental
effects; and (c) genes influenced by cis-acting elements are readily identified because they must
account for some or all of the allelic imbalance. The final and most crucial advantage of the ASE
approach is that, because genetic factors that influence transcriptional regulation in cis are
generally in close proximity to the gene itself, identification of a cis-acting regulatory element
essentially identifies a specific gene or locus that contains the polymorphism leading to the allelic
imbalance. In other words, identification of a SNP exhibiting ASE essentially identifies a high-
confidence candidate gene (genetic factor) with expression differences that may account for the
complex trait.
The rationale for integrating both genetics and functional genomic approaches is that the
strengths of each system can be combined to yield results of higher confidence. Given the large
volume of data produced by genomics, each method provides an additional screen to limit the
number of targets to verify and characterize in future experiments. The following examples
represent the primary efforts that have employed integrative genomic approaches to identify
specific disease-resistance genes as well as to provide fundamental biological information.
MAREK’S DISEASE
Rationale for Enhanced Genetic Resistance
Marek’s disease (MD) is a T cell lymphoma disease of domestic chickens induced by Marek’s
disease virus (MDV), a naturally oncogenic, highly contagious, and cell-associated a-herpesvirus
(13, 14). The disease is characterized by a mononuclear infiltration of the peripheral nerves,
gonads, irises, various viscera, muscles, and skin. Partial or complete paralysis is a common
symptom of MD owing to accumulation and proliferation of tumor cells in peripheral nerves.
During the 1960s, as the industry converted to high-intensity rearing, MD generated tremendous
economic losses. Since the 1970s, MD has been controlled by vaccination and improved animal
husbandry. However, even with vaccines, estimated annual losses worldwide fromMD owing to
meat condemnation and reduced egg production are $1–2 billion (15). Although vaccination
prevents the formation of lymphoma and other MD symptoms, it does not prevent MDV in-
fection, replication, or horizontal spread (16).Moreover, even though available vaccines protect
chickens against the disease, MD still remains a threat owing to increasingly frequent outbreaks
caused by highly virulent strains of MDV combined with the incomplete immunity that is
elicited by vaccination (17–19). Thus, to break the cycle of MDV evolving to higher virulence,
knowledge supporting the development of new strategies for control of MD is needed. For
this reason, increasing genetic resistance to MD is highly desirable.
Pre–Genome Sequence Efforts
Genetic differences in resistance to fowl paralysis, assumed to be MD, have been reported for 70
years (20). Although genetic resistance toMD is complex and controlled bymany genes, theMHC
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(also known in the chicken as theB complex because of its linkagewith the Bblood group) is clearly
a major locus. Prior to modern genomics, the MHC was shown to be associated with MD re-
sistance (21). Cole’s (22) selection of the B-G (class IV) locus through blood-typing resulted in
dramatically differentMD incidences (7% and 94% in Cornell lines N and P, respectively), which
clearly demonstrates that it is possible to enhance genetic resistance toMDgiven the right selective
pressure and without the need for DNA-based markers. Because no differences between the two
lines are observed during the first week of infection,MHC resistancemay result from factors other
than the number or type of target cells present early after infection (23, 24).
In addition to the MHC, other genetic factors exert a major influence on MD resistance. For
example, Avian Disease andOncology Laboratory (ADOL) inbred line 6 and 7 chickens share the
same B2 haplotype (25) but differ greatly in resistance to MD. In contrast to MHC-controlled
resistance, non-MHC genetic resistance can be related to the number of target cells. Spleen and
thymus cells from line 6 birds are infectedwith lessMDV than similar cells from line 7 (26, 27). The
sizes of the primary lymphoid organs (thymus and spleen) and the number of lymphocytes in line 6
chickens are also significantly smaller than in line 7 chickens (28–30).
Apart from a few candidate gene studies [e.g., Rfp-Y (31), vitamin D receptor (32)], most
efforts to identify MD resistance genes have used genome-wide QTL scans with microsatellite
markers. Two studies utilizedADOL lines 6 (MD resistant) and 7 (MD susceptible). Vallejo et al.
(33) and Yonash et al. (34) identified 14 QTLs (7 significant and 7 suggestive) where, col-
lectively, theQTLs explained up to 75%of the genetic variance. Interestingly, bymeasuring not
only disease incidence but also disease-related traits, the QTLs could be grouped by trait type.
Some QTLs were associated almost exclusively with viremia levels and the remaining QTLs
with disease, survival, tumor incidence, nerve enlargement, and other disease-associated traits,
which suggests that disease resistance occurs at least at two levels: initial viral replication and
cellular transformation. Similarly, Bumstead (35) mapped a single significant QTL on chro-
mosome 1 that had conserved synteny with the mouse CMV1 locus, which controls resistance
to murine cytomegalovirus, another herpesvirus. Ly49H is the causative gene for CMV1
resistance, and the encoded protein is a receptor on natural killer cells that interact with
MHC class I (36).
Two other studies used commercial layer (egg-type) lines that allowed for larger populations
and industrially relevant results. Using microsatellites genotyped on DNA pools from selected
individuals, McElroy et al. (37) identified 17 markers of the 81 screened to be associated with
length of survival post-MDV infection. Heifetz et al. (38) identified 15 QTLs on two consecutive
backcross (BC) populations; however, only 5 of the QTLs were common to both BC populations.
The second BC hatch showed an MHC association, although the B2 allele was unexpectedly
found to confer susceptibility. The interaction of theMHCwith other background genes had been
observed previously (39).
To complement the QTL scans, gene expression profiling using microarray technology has
been integrated. The rationale is that gene expression profiling will identify genes and pathways
involved in MD resistance, which, combined with genetic mapping, can reveal positional candi-
dategenes (40). In otherwords, positional candidate genes are those that have a genetic association
and are identified as being relevant through gene expression analyses. Gene profiling has been
conducted to identify differentially expressed genes between MD-resistant and -susceptible lines
afterMDV challenge (40, 41); amongMHC-congenic lines of chickens following inoculationwith
different MD vaccines; in chicken embryo fibroblasts (CEF) infected with MDV (42); and in CEF
transformed with Meq, the likely MDV oncogene (43). Several genes and pathways are consis-
tently associatedwith eitherMDresistance orMDV infection, and the results suggest that chickens
with immune systems that are more stimulated by MDV infection are more susceptible. Because
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MDV is thought to infect only activated lymphocytes, chickenswith immune systems that aremore
responsive may present more targets for MDV to infect and later transform.
MDV-chicken protein-protein interactions provided additional evidence that genes are as-
sociated with MD resistance. Niikura et al. (44) screened for MDV-chicken protein-protein
interactions using a two-hybrid screen confirmed by an in vitro binding assay and identified
nine such interactions. Of particular interest were growth hormone (GH1) (45), stem cell
antigen 2 (SCA2) (46), and MHC class II b chain (B-LB), because the transcripts for each gene
were differentially expressed between MD-resistant and -susceptible birds following MDV
infection, and there is an association with MD resistance. Also, GH1 allele frequencies have
changed in response to selection for MD resistance (47), which supports growth hormone as
an MD-resistance gene. Novel upregulation of both MHC class II, following MDV infection
(48), and vitamin D receptor (VDR), which modulatesMHC class II cell surface expression and
is associated with MD resistance (32), further supports MHC class II b chain as a candidate
gene for MD resistance.
Protein profiling using mass spectrometry, a powerful technique that can query the proteome,
was conducted on UA-01 cells, a MDV-transformed cell line (49). Prior work had indicated that
MD tumors overexpress CD30 and, thus, might be a natural model for human T cell lymphomas
(50). Bioinformatic analysis of the data indicates that MD tumor cells have a pattern that is
consistent with other tumors and are probably derived from regulatory T cells.More importantly,
the prometastatic integrin andERK/MAPK signaling pathwayswere predominant,which suggests
that these pathways are important for transformation and migration of MD tumors. Similar
studies by Liu et al. (51) have cataloged the spectrum of MDV proteins expressed.
Post–Genome Sequence Efforts
Given the difficulty of purely genetics-driven approaches to identify high-confidence candidate
genes, alternative efforts have been employed. MacEachern et al. (52) incorporated a genome-
wide ASE screen for chicken non-MHC genes that respond toMDV infection. In this study, using
an RNA sequencing data set, SNPs were first identified, and then the ratio of the two alleles
in uninfected and MDV-infected animals was determined. If the expression ratio changed in
response to viral infection, it indicated that there was a cis-acting regulatory element affecting the
expression of the gene, thus identifying a genetic element in the gene containing the SNP.
In brief, ADOL lines 6 (MD resistant) and 7 (MD susceptible) were intermated to produce F1
progeny. Half of the progeny were challenged withMDV at 2 weeks of age. At 1, 4, 7, 11, 13, and
15 days postinfection (dpi), 12 birds from each treatment group were euthanized, and RNA from
the spleen was isolated. To get a genome-wide and unbiased survey of all the expressed genes and
an indication ofASE, replicate RNApools froma single time point (4 dpi)were sequenced using an
Illumina GA. This resulted in 11millionmapped reads per treatment groupwith a total of> 1.7
Gb surveyed. Statistical analysis revealed that 5,360 (in 3,773 genes) of the 22,655 high-quality
SNPs identified exhibited statistically significant allelic imbalance; gene expression was detected
for 12,696 genes. To validate and extend the results, 1,536 selected SNPs were screened on RNA
samples from all 456 F1 birds using Illumina GoldenGate arrays. Allelic imbalance was confirmed
in 861 (70%) of the 1,233working assays. Infectionwas found to greatly impact the expression of
alleles from these genes over time, and significant differences in ASE were detected between
infected and uninfected individuals at all time points. The identified genes and pathways (e.g., cell
proliferation, apoptosis) are consistent with what is thought to be the case for MD genetic re-
sistance. Thus, it was concluded that ASE is a powerful approach to identify regulatory variation
responsible for differences in transcript abundance. Experiments are currently underway to
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answer the major question, which is whether the SNPs showing ASE are also associated withMD
genetic resistance.
Smith et al. (53) also profiled gene expression in line 6 and 7 birds following MDV infection.
RNAwas isolated at 2, 3, and 4 dpi to concentrate on the innate immune response. As is typical for
microarray-based studies, several genes and pathways were altered in comparing the two lines of
chickens.Most interesting, however, was the enrichment ofHIC1 binding sites in the promoters of
genes that were repressed in response to viral infection. HIC1 is a transcription factor that drives
antitumor mechanisms. This would suggest that MDV is actively suppressing antitumor mech-
anisms. This type of analysis would not have been possible without the chicken genome sequence.
Furthermore, by conducting association analyses in MD resource populations, it was shown that
IRG1 has a potential role in MD susceptibility.
A direct approach to identify MD resistance genes and pathways takes advantage of the fact
that MDV Meq, the viral oncogene, is also a bZIP transcription factor. Thus, one can employ
chromatin immunoprecipitation using antibodies directed against Meq, followed by next-
generation sequencing, to identify the regions in the chicken genome to which Meq binds. In-
tegrating DNA microarrays to compare cells expressing Meq with those that do not theoretically
allows one to identify all the genes directly regulated by Meq. Furthermore, motif analysis of the
Meq-bound sites provides opportunities to account for ASE between lines 6 and 7. Preliminary
results using this strategy have been reported (54).
To summarize, through a combination of genetic and functional genomic approaches, a large
number of candidate genes have been identified, which confirms the multigenic nature of MD
genetic resistance. Experiments are under way to determine if MAS based on thousands of can-
didate genes and SNPs can select for and against MD resistance as well as to provide information
on how transferable the genetic markers are across various populations (H.H. Cheng, manuscript
in progress).
Salmonella
Rationale for enhanced genetic resistance. The importance of Salmonella as both a poultry and
a food-safety pathogen, along with the recognition early in the twentieth century of a heritable
basis for host resistance to Salmonella (55), has resulted in a long history of investigation into the
genetics and genomics of resistance to Salmonella in chickens. Depending upon the bacterial
species, Salmonella can either be highly pathogenic or cause virtually no response in the host.
Salmonella enterica serovars Gallinarum and Pullorum, both of which cause systemic salmo-
nellosis, lack flagella and therefore are not recognized effectively by Toll-like receptor 5 (TLR5)
such that there is no strong inflammatory response to help limit the infection to the gut (56). The
inflammatory reaction induced by Salmonella Typhimurium and Salmonella Enteritidis (SE)
often limits the infection to the gastrointestinal tract, where it may establish a carrier state and
become a potential source of poultry-product contamination.
Birdswith subclinical salmonellosismay remain in production flocks and transmit the zoonotic
bacteria into the food chain (57). Chicks infected with Salmonella upon hatching can be colonized
persistently, and the bacteria can infect table or hatching eggs laid by adult hens (58). SE accounts
for over three-fourths of the cases of food-borne salmonellosis (59). Chicken consumption is
amajor risk factor in SE infections (60).Over onemillion cases of human infectionwith Salmonella
species occur each year in the United States alone (61). In addition, reduced growth and re-
productive performance can occur as a result of microbial infection, even at subclinical levels (62).
Poultry resistance to Salmonella has provided a durable example of the integration of diverse
genetic and genomic approaches to elucidate the host genes, networks, and QTLs associated with
246 Cheng  Kaiser  Lamont
A
nn
u.
 R
ev
. A
ni
m
. B
io
sc
i. 
20
13
.1
:2
39
-2
60
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
 
A
cc
es
s p
ro
vi
de
d 
by
 Io
w
a 
St
at
e 
U
ni
ve
rs
ity
 o
n 
11
/1
1/
15
. F
or
 p
er
so
na
l u
se
 o
nl
y.
resistance. The essential first stage in such studies is to determine that a genetic basis does indeed
underlie the traits of interest; this establishes the feasibility of identifying the specific genetic
components controlling resistance and thereby the potential to enhance host resistance by genetic
or genomic selection. Complex disease phenotypes often are divided intowell-defined components
of the response, each of which typically has higher heritability than the total response. Heritability
of chick survival after Salmonella challenge ranged from 0.14 to 0.62 (63); number of bacteria in
internal organs, 0.02–0.29 (64); cecal carrier state, 0.06–0.20 (65); and spleen and cecal con-
tamination, 0.13–0.47 and 0.24–0.53, respectively (66).
The estimated heritabilities of parameters of response to Salmonella, as well as the differences
between distinct genetic lines of chickens (67), strongly suggest that there is partial genetic control
of most response phenotypes and, therefore, that genetic selection to improve resistance to
Salmonella carrier state and salmonellosis is feasible. Genetic selection can be based on variation
in genomic structural or expression-level variation (63, 68–70).However, studies to date suggest
that many genes are associated with genetic control of response to Salmonella, and the effect of
most individual genes is rather small (see 71–75).
Candidate gene studies: structural polymorphisms. Strategies used to identify the genetic control
of resistance to Salmonella have spanned the spectra from gene-centric to genome-wide and from
variation in structure to variation in expression. They have also capitalized on the strengths of
using varied population structures, including inbred and congenic lines, diverse genetic pop-
ulations, and outbred commercial lines. Outbred populations possess extensive phenotypic di-
versity for traits such asmorphology, behavior, anddisease susceptibility, predominantly owing to
underlying genetic diversity. Understanding the relationship between DNA sequence poly-
morphism and the variability observed for complex traitswill increase opportunities for predicting
disease risk and also, in the case of livestock, allow selective breeding programs to maximize
improvement for the trait of interest. Both commercial and inbred lines of chickens differ in innate
immune responses to pathogen challenge. This correlates with disease resistance, and the dif-
ferential responses are under genetic control (67, 76–78).
Early candidate gene studies on the molecular basis of Salmonella resistance in chickens ef-
fectively useda comparative approachby examining the role ofmajor loci that control resistance of
mice to Salmonella Typhimurium infection. One-third of the differential resistance in mortality
after Salmonella infection in a BC of inbred chicken lines was associated with variation in the
natural resistance–associated macrophage protein 1 (NRAMP1, now termed SLC11A1 as
amember of the solute carrier gene family) and tenacinC (TNC,whichwasusedas amarker for the
nearby lipopolysaccharide, or LPS, locus, known to control response to LPS in mice) (79).
Successful investigation of these biological candidate genes led the way to identification of other
positional and biological candidate genes. Located near the TNC locus is TLR4 (formerly LPS),
which encodes the receptor that binds LPS, a major component of gram-negative bacterial
membranes such as Salmonella. TLR4 was associated with response to Salmonella in chickens
(80,81). Associations with both SLC11A1 and TLR4 have subsequently been demonstrated
across a wide range of Salmonella-response phenotypes and chicken populations (72–75).
Many biological candidate genes have been associated with host response to Salmonella. A
major biological candidate gene region, the MHC, was selected for investigation because of
its association with many other disease-resistance traits. Once again, specialized experimental
populations served as an effective target of study; B-complex (MHC) congenic lines revealed
differences in mortality and morbidity after Salmonella challenge (82), and polymorphism in
MHC class I genes was associated with other Salmonella-response traits in experimental line
crosses (83, 84).
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Other candidate genes have been identified by their hypothesized roles in important pathways
of host response to Salmonella. Cytokines are essential communication molecules secreted by
immune system cells and other tissues. They serve a primary role in modulating pro- and anti-
inflammatory responses and indirecting appropriate adaptive immune responses.Genetic variants
in cytokines and related genes have been associated with numerous Salmonella-resistance phe-
notypes (85–87). The antimicrobial b-defensin peptides serve in the innate immune response
against bacteria (88). Structural variants in severalb-defensin genes were associatedwith bacterial
load in the cecal content or spleen tissue after Salmonella challenge (89). Apoptosis, or pro-
grammed cell death, is an important functional feature of the immune system, and genes in
apoptotic pathways (CASP1 and IAP1) have been associated with Salmonella persistence in
internal organs in both experimental crosses and commercial broilers (85, 90).
Experiments that test associations between candidate genes and Salmonella resistance can
seldom reject the possibility that the causal gene could be a nearby, rather than the specific, gene
tested because of LD between the tested marker and nearby genes. Therefore, additional sup-
porting lines of evidence, including verification in independent populations, either by gene ex-
pression data or with genome-wide QTL scans, add confidence to the detected gene-resistance
phenotype associations. In addition to studies of tissues from animals infected with Salmonella,
insights into resistance mechanisms can be gained by intensive analysis of isolated, relevant cell
types and in vitro systems. For Salmonella infections, heterophils and macrophages are key re-
sponder cell types.
Expression variation: targeted genes to global arrays. Gene-targeted studies of mRNA expres-
sion changes associated with Salmonella infection in chickens have focused on three main
gene families: TLRs, cytokines, and b-defensins. The TLRs are pattern-recognition receptors
(PRRs) that initiate immune response after detection of pathogen-associatedmolecular patterns.
After SE challenge, TLR4 expression differed between chicken lines with different levels of
resistance to Salmonella (91). Diverse genetic lines of chickens exhibit different expression
patterns of up- and downregulation of TLR2, TLR4, and TLR5 in the spleen in response
to Salmonella infection (92). Downregulation, rather than the expected upregulation, of
TLR5, which recognizes bacterial flagella, supposedly has the beneficial effect of protecting
host cells from overstimulation (93). Expression of TLR15, an avian-unique TLR, differed
in heterophils isolated from broiler breeder chicken lines that differ for resistance to
Salmonella (94).
Salmonella infection induces expression of multiple chemokines, cytokines, and their receptors
in a variety of chicken tissues. After Salmonella infection, distinct chicken breeds express different
profiles of expression in the spleen or cecum, including IL10, IL12A, IL12B, IL18, CCLi2, and
CXCLi2, which may explain some of the general breed differences in immune response (95, 96).
Comparing four lines of broilers, including two parental lines and their F1 crosses, the heterophils
from the two phenotypically resistant lines, after isolation and treatmentwith SE, had higher levels
of expression of the proinflammatory cytokines IL6, IL8, and IL18 and lower levels of the anti-
inflammatoryTGFB4 than the two susceptible lines (97). Responses to SEof heterophils from lines
that had undergone commercial selection for meat or egg production differed from those of
heterophils from an unimproved line, which had increased expression of pro- (IL6 andGM-CSF)
and anti-inflammatory (IL10 and TGFB4) cytokines (98). Macrophages isolated from blood of
resistant and susceptible lines of chickens produced cytokines with different kinetics and levels,
including more rapid and higher levels of IL18 in the resistant line, which suggests that Th1
adaptive immunity is important in protective responses (99). Although studies conducted with
a variety of genetic lines, challenge species of Salmonella, timing, and cells or tissues show some
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variation in results, IL1a, TNFa, IFNG, IL12, IL15, and IL18 generally appear to be associated
with a protective role, and IL4 and IL10 with inhibition of host defenses against Salmonella.
Because antimicrobial peptides are an important component of the innate immune response to
pathogens, the rapid expression of avian b-defensin (AvBD) genes after infection is likely im-
portant in resistance. Expression of AvBD genes in leukocytes was increased significantly within 6
h in response to SalmonellaTyphimurium infection of broilers (100). Inbred chicken lines differing
in cecal bacterial carriage showed marked differences in expression of AvBD1 and AvBD2, with
higher expression in the line with the lower bacterial carriage (91). Salmonella infection interfered
with AvBD2 expression in the cells from a susceptible, but not a resistant, line (101). Collectively,
these studies reinforce the concept of an important role of the b-defensins in Salmonella resistance
in chickens.
Although it is rapidly being replaced by sequencing-based technologies, large-scale expression
profiling using microarrays has been a powerful tool to identify genes and biological pathways
associatedwithSalmonella infection phenotypes. Abroadpicture of the transcriptional differences
that occur in response to Salmonella infection, or between resistant and susceptible phenotypes,
can serve to direct future, targeted studies of gene function to identify the causal genes of Sal-
monella resistance. Both immune-centric and global expression microarrays have been used.
Immune-centric arrays are produced by selective placement of probes from immune system genes
or are produced from tissues relevant to the immune response. This approach increases the
likelihood that a large percentage of the included elements will be involved in response to infection
with Salmonella. Global arrays broadly represent all gene categories and have the potential to
discover novel pathways not identified previously with resistance phenotypes. Global arrays can
also serve as consistent platforms across studies of diverse physiological traits and therefore help to
integrate information about gene networks that interconnect many biological functions.
Studies have been conducted on Salmonella response and a variety of tissues or cell types using
immune-centric microarrays. Both infection status and genetic line have major impacts on dif-
ferences in gene expression. In a study of intestinal tissue from two broiler lines, genes of the innate
immune system and wound healing were upregulated after Salmonella infection (102). The lines,
however, differed in expression of genes involved in inflammation, acute phase response, fi-
brinogen system, and actin-polymerization pathways. In a related study, line-specific responses to
Salmonella included genes related to T cell activation and macrophage function (103). Tran-
scriptional profiles of the HD11 chicken macrophage cell line after SE infection were assayed
on a 5K microarray generated from activated macrophages/monocytes (104). The chemokine
ah294 (CCL5 or RANTES) had the highest expression, and IL6 and antiapoptotic genes were
also upregulated. Genes associated with cell proliferation, adhesion, and transcription were
downregulated.
Using a chicken 13K cDNAglobal arraywith transcripts derived from24 tissue and cell sources
(105), many cytokines, chemokines, and genes related to apoptosis and T cell functions were
significantly differentially expressed in spleen between SE-inoculated and noninoculated chicks, as
well as between chicks with high and low bacterial burden (106). With the same microarray,
diverse genetic lines of birds were shown to preferentially use different biological systems in their
early, innate response to Salmonella infection. One line predominantly used immune response;
another line, apoptosis and nonimmune cellular responses; and the third line, immune defense
mechanisms (S.J. Lamont & H. Zhou, unpublished data).
Heterophils from relatively resistant and relatively susceptible commercial broiler lines ex-
posed to SE in vitro were evaluated for transcriptional profile using a 44K global array (107). The
susceptible line had more downregulated immune-function genes than the resistant line. Immune-
related genes that were upregulated in the resistant line included members of the TLR-signaling
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pathway and genes that activate T helper cells. Analysis of the chickenHD11macrophage cell line
after stimulation with Salmonella-derived endotoxin, using the same 44K array, showed that the
NFKBIA, IL1B, IL8, andCCL4 genes were induced. Expression of the intracellular PRRNLRC5
(aNOD-like receptor familymember) was also induced, which signified the first demonstration of
its potential function in the response to Salmonella in chicken macrophages (108).
Although varied experimental designs andmicroarray platforms have generated varied results,
some consistent pictures emerge from use of this experimental approach regarding important
pathways associated with response to Salmonella. Strong candidates for genetic control of
Salmonella in poultry, as identified through large-scale transcriptional profiles, include TLR,
cytokine, and antimicrobial b-defensin genes, as well as genes involved in T cell function and
apoptosis.
QTLs: from genomic regions to genes. Identification of QTLs for response to Salmonella has
progressed over time, from the use of low-density microsatellite markers; through moderate-
density SNP panels (8); to the current, routine genotyping of over one-half million SNPs. The
increasing marker density allows increasingly fine mapping of the QTL location, which facilitates
identification of the specific causal genes or nucleotides underlying the QTL.
The most prominent example of QTL mapping is the identification of SAL1. Mariani et al.
(109) identified a significant linkage between spleen colonization with Salmonella and genetic
markers on chromosome 5 and named the QTL SAL1. Subsequent fine-mapping of the SAL1
region revealed two strong functional candidates for Salmonella response: AKT1 (protein kinase
B, or PKB) andCD27bindingprotein (SIVA) (76). Fine-mapping of heterophil functional response
to Salmonella in a highly advanced intercross strongly supported the SAL1 QTL position con-
tainingAKT1 and SIVA and suggested heterophil function as a specific mechanism to explain the
host-resistance properties that map to this region (110).
ManyQTL regions associatedwith resistance to Salmonella carrier state, antibody response,
or salmonellosis have been identified through genome scans located widely throughout the
genome (69, 77, 111–114). This largeQTLnumber supports the highly polygenetic nature of the
host response, but QTLs with effects as large as 37% of the phenotypic variance in carrier state
have been identified (111). SomeQTLs are in regions known to contain immune-response genes,
such as the MHC (111), or in regions in which previous studies have identified associations of
gene SNPs with Salmonella-response phenotypes (82, 83). Locations of QTLs have also been
verified from experimental to commercial populations (115), which demonstrates the effec-
tiveness of using experimental populations to identify QTLs of value in commercial application.
QTLs associated with response to both SE and Escherichia coli have also been identified (116),
suggesting that someQTLs are associated with general properties of response to bacteria, which
may make them especially useful in selection for improved resistance. The convergence of
multiple lines of evidence for genomic control of host resistance to Salmonella, using in-
dependent populations and different strategies, strengthens confidence in the true existence of
these QTL associations and encourages detailed study of these genomic regions to identify the
causal mutations.
Campylobacter
Rationale for enhanced genetic resistance. Campylobacter is the leading cause of acute enteritis in
humans, and infections may be complicated by severe sequelae, including inflammatory neu-
ropathies and reactive arthritis. In the United Kingdom, there were 65,000 laboratory-confirmed
cases of human infection in 2009 (a 17% rise over the preceding year), and eight times as many
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cases are estimated to be unreported (117). It is thought that 20–30%of cases result fromhandling
or consuming contaminated broiler meat, and up to 80% of cases are attributable to the chicken
reservoir as a whole (118). Campylobacter was detected in 65% of chicken samples on retail
sale in the United Kingdom during 2007–2008 (119), and a pressing need exists for strategies to
reduce entry of Campylobacter into the food chain. That on-farm control of Campylobacter is
required to reduce the incidence of zoonosis is widely acknowledged.
Campylobactermaybe a part of the normal avian gut flora owing to the asymptomatic carriage
of the bacteria (i.e., essentially a commensal); therefore, at first consideration resistance to col-
onization would seem unlikely. However, increasing evidence suggests that, rather than being
a commensal of the chicken, Campylobacter is actually a very accomplished pathogen. Cam-
pylobacter jejuni can colonize up to 108 colony-forming units per gram of intestinal content, has
the ability to invade the intestinal mucosa (120), and generates an antibody response during
colonization (121). Campylobacter induced proinflammatory cytokines and chemokines in
a chick epithelial cell model (122), and infection of chickens with Campylobacter induced a rapid
influx of heterophils (the avian functional equivalent of the mammalian neutrophil) into the gut
and the production of proinflammatory cytokines and chemokines in the intestinal epithelium
(123). Such data indicate that Campylobacter can induce typical innate immune responses, al-
though these are time- and magnitude-limited compared with similar responses induced by
Salmonella serovars. The surface of Campylobacter is decorated with a plethora of carbohydrate
moieties that may enable it to evade activation of avian innate immunity and thereby colonize
poultry by stealth. Bacterial pathogens associated with enteric fever use such strategies (124),
and it is noteworthy that C. jejuni can sometimes be found in deep muscle and visceral organs.
C. jejunimay evade detection by avian TLR5, because mutant strains lacking genes responsible
for glycosylation of the flagella elicit stronger proinflammatory cytokine responses in chick ceca
and exhibit defects in intestinal persistence relative to the parent strain (125). Salmonella
Typhimurium strains expressing the C. jejuni proteins CjaA or Peb1A elicit protection against
intestinal colonization of chickens by C. jejuni (126), which suggests that immune control of
C. jejuni in the avian intestines may be feasible.
Host variability inCampylobacter colonization of the chicken intestine was observed in young
chicks over twenty years ago (127), and resistance to cecal colonization byC. jejuni is significantly
influenced by the chicken host lineage (128). Boyd et al. (128) examined the ability of C. jejuni to
colonize the intestines of four different inbred lines for 2–3 weeks postinoculation on the day of
hatch. There was a consistent ten- to one hundred–fold difference between the four inbred lines in
the number of C. jejuni present in the cloaca or in the ceca; the greatest differences were detected
between line N, which carried relatively high bacterial levels, and line 61, which carried relatively
low numbers of bacteria. The MHC apparently was not a major factor in determining the re-
sistance. The difference in numbers of colonizing bacteria was observed as early as 24 h after
challenge and was still present at the end of the experiment. The effect appears independent of
bacterial strain and age of bird; it was evident with both strain 14N and strain 81176 in newly
hatched line 61 versus line N chicks (128) and in birds challenged at three weeks of age with strain
11168H. Reciprocal BC experiments between lines N and 61 revealed that the difference in
bacterial numbers was heritable (128), which suggests the possibility of identifying the genes
responsible by genetic mapping and candidate gene analysis.
Genome-wide and functional genomic scans. Despite associations between several Campylo-
bacter genes and colonization (129), little is known about host gene associations with resistance to
Campylobacter colonization. In our recent study (P. Kaiser, J. Howell & M. Fife, unpublished
data), we used lines 61 (resistant) andN (susceptible) in a BC experimental design. A total of 1,243
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SNP markers, fully informative for the two lines, were used in a genome-wide screen for the
identification of QTLs associated with levels of Campylobacter gut colonization in the first few
dpi. Analysis of log-transformed cecal bacterial levels between the parental lines revealed a sig-
nificant difference on all four dpi (P< 0.05). FourQTLswere identified through analysis of the BC
(F1xN) population. These included one genome-wide significant QTL on chromosome 11 at ∼12
Mb and a QTL on chromosome 7 at ∼28 Mb, which was highly significant at the chromosome-
wide level. Two further QTLs on chromosomes 12 and 27, at ∼18 Mb and ∼1 Mb, respectively,
were also significant at the chromosome-wide level.
Four QTLs for resistance to colonization with Salmonella Typhimurium were identified in
a similar BC between lines 61 andN (77). Three of themwere at different genomic locations than
the four QTLs identified in this study; the fourth was at the distal end of chromosome 12,
overlapping significantly with the QTL identified at the distal end of chromosome 12 in this
study. The 1-LOD-drop intervals of the two chromosome 12 QTLs cover approximately 3.5
Mb, although the QTLs could extend to the end of chromosome 12 (20.5 Mb). This is a
comparatively gene-poor region of the chicken genome, with only 75 genes annotated, as well
as onemicroRNAand one novel small nucleolar RNA.Among these there are several interesting
candidate genes, including some involved in signaling leading to transcription and others with
a more intriguing potential role in resistance to bacterial infection. For example, interleukin-1
receptor-associated kinase-like 2 (IRAK2) is one of two serine/threonine kinases that associate
with the IL1 receptor upon stimulation, and it plays a role in upregulation of NF-kB. NF-kB
signaling has a role in the induced innate responses to both Salmonella and Campylobacter
infection inmammals, driving production of the proinflammatory cytokines IL1b, IL6, IL8, and
TNFa. Infection of chickens with Salmonella (130, 131) orCampylobacter (121, 123) drives the
production of IL1b, IL6, and IL8, presumably throughNF-kB. Other genes in this region whose
products have a role in signaling are PP4R2 (serine/threonine-protein phosphatase 4 regulatory
subunit 2); RYBP (RING1 and YY1 binding protein), a repressor protein for transcription
factors; and LRIG1 (leucine-rich repeats and immunoglobulin-like domains 1), which interacts
with receptor tyrosine kinases of the EGFR family. Caveolin 3 (CAV3) plays a crucial role in
endocytosis but also provides a scaffold for signaling molecules. Leiomodin 3 (LMOD3) is an
actin filament nucleator. Finally, GHRL encodes the peptide hormones ghrelin and obestatin,
which in mammals are thought to be produced in the cells lining the stomach and small in-
testine (132). Though the influence of obestatin on Campylobacter is unknown, the stress-
related catecholamine hormone noradrenaline activates growth, motility, and invasion by
C. jejuni (133), and it is plausible that other examples of such interkingdom signaling exist.
Polymorphisms in any of the genes identified could influence susceptibility to colonization by
either Salmonella or Campylobacter.
Li et al. (134–136) used the complementary approach of whole-genome gene expression
analysis by microarray to compare responses to Campylobacter infection between two parental
commercial lines of chickens that also differ in resistance to Campylobacter colonization (137).
They demonstrated differential responses between the lines and between infected and noninfected
birds. In the spleen,more geneswere differentially expressed in response to infection in the resistant
line than in the susceptible line. Specifically, genes for lymphocyte activation, differentiation, and
humoral responses were upregulated in the resistant line, whereas genes for regulation of
erythrocyte differentiation, hemopoiesis, and RNA biosynthesis were all downregulated in the
susceptible line. An interaction analysis between genetic lines and treatment demonstrated distinct
defense mechanisms between lines: the resistant line upregulated genes involved in apoptosis and
cytochrome c release from mitochondria, whereas the susceptible line responded by down-
regulating genes involved in both functions (137).
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CONCLUDING THOUGHTS: CHALLENGES AND OPPORTUNITIES
Steady progress clearly has been made in identifying the genetic determinants of resistance for
several poultry diseases as well as in gaining a greater understanding of the underlying biology.
This progress will continue using the methods mentioned, as well as new ones, which are difficult
to predict though they are usually adopted readily and havemajor impact. Of particular interest is
the implementation of genomic selection, in which genetic markers evenly spaced throughout the
genome are able to capture themajority of the genetic variation for complex traits (138). Owing to
its promise, all major poultry-breeding companies are evaluating this new and exciting method,
which is equal, if not superior, to best linear unbiased prediction, the current state-of-the-art
method for breeding (139, 140; H.H. Cheng, unpublished data). Although selection for enhanced
disease resistance is one of the most discussed advantages for genomic selection, many scientific
(e.g., analysis) and logistical (e.g., SNP chip cost) problems must be resolved before it can be
implemented on a routine basis.
It is also becoming apparent that biology is muchmore complex than long thought. Fields such
as epigenetics, RNA modification, alternative splicing, and microRNAs indicate that complete
biological knowledge will require in-depth information at multiple levels. Thus, efforts must be
made to annotate the chicken genome at a level similar to that of human and other model
organisms (141). Similarly, the interplay of nutrition and gut microbes is becoming increasingly
important in understanding not only gut function but also overall host immune responses (142).
Thesemetagenomic studies offer the potential to identify specific determinants of environmental
factors for complex traits, may partially explain the growth-promoting action of antibiotics, and
provide new and fertile avenues for enhancing disease resistance.
In closing, it is an extremely exciting period for biologists. New findings and technologies are
bringing closer the ever-elusive goal of bridging from genotype to phenotype. Ultimately, com-
bining existing and new technologies should allow for precise and economical genetic selection of
poultry for enhanced disease resistance, which will lead to enhanced animal welfare, productivity,
and food safety.
SUMMARY POINTS
n Thepoultry industry needs to enhance genetic resistance for infectious diseases to enhance
animal health and welfare, for profitability, to maintain consumer confidence, and as
a means to augment current animal husbandry and vaccines.
n With the chicken genome sequence andpowerful tools (e.g., high-density SNPchips, next-
generation sequencing), the field of genomics can identify genes and geneticmarkers that can
be used to increase genetic resistance or improve vaccinal response to specific pathogens.
n Owing to the difficulty of identifying specific genes that account for disease resistance
using QTL-mapping efforts alone, integrated genomic approaches (e.g., transcript pro-
filing to provide candidate genes for use in association studies) are required.
n Owing to its simplicity and power, allele-specific expression (ASE) screening is one of the
more promising approaches to identify candidate genes. It is especially amenable for
disease resistance studies because it compares RNA derived from two states only (un-
infected versus infected birds).
n Integrated efforts to identify disease resistance for Marek’s disease, Salmonella, and
Campylobacter have successfully identified many genes and other strong candidates as
well as provided information on the biological pathways involved in the response to the
pathogens.
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FUTURE ISSUES
n If breeding values of markers for disease resistance are determined, then genomic
selection of unchallenged individuals usingmarkers spaced throughout the genomewill
become an attractive method for poultry-breeding companies to select for enhanced
disease resistance.
n Given the power and precision of next-generation sequencing, enormous data sets will
be produced that will provide increasing insights into complex traits such as disease
resistance. However, there will be significant bioinformatic challenges to properly
handling and analyzing the data.
n To address the increasing complexity of disease resistance, the majority of chicken genes
must be experimentally annotated using functional data from chickens.
n New technologies, like those developed in the past (e.g., PCR, automated sequencing,
microarrays), will continue to play important but unpredictable roles in genomics.
n As always, phenotype remains key and is often the rate-limited step. Many disease
problems in the poultry industry are not caused by single pathogens but rather are
syndromes caused by multiple pathogens and exacerbated by stress or nutritional
challenges. Defining which phenotypes to measure in these complex challenges to
quantify disease resistance will require a deeper understanding of their pathology.
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